Indeed, analyses in other cancers reinforce this concept: in colorectal cancer, high ZDHHC9 was associated with worse survival and was shown to promote tumor growth by upregulating PD-L1 and blunting CD8+ T cell immunity (31). The gene discussed is ZDHHC9; the disease is cancer.